Proprietary AI analyst is now available

Procter & Gamble Valuation Multiples

Discover Procter & Gamble's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like AbbVie, L'Oreal, Novo Nordisk, Unilever and more.

Procter & Gamble Overview

About Procter & Gamble

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.


Founded

1905

HQ

United States

Employees

109.0K

Website

us.pg.com

Financials (LTM)

Revenue: $87B
EBITDA: $24B

EV

$353B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Procter & Gamble Financials

Procter & Gamble reported last 12-month revenue of $87B and EBITDA of $24B.

In the same LTM period, Procter & Gamble generated $44B in gross profit, $24B in EBITDA, and $17B in net income.

Revenue (LTM)


Procter & Gamble P&L

In the most recent fiscal year, Procter & Gamble reported revenue of $84B and EBITDA of $24B.

Procter & Gamble is profitable as of last fiscal year, with gross margin of 51%, EBITDA margin of 28%, and net margin of 20%.

See analyst estimates for Procter & Gamble
LTMLast FY202320242025202620272028
Revenue$87B$84B$83B$84B$86B
Gross Profit$44B$43B$41B$43B$44B
Gross Margin50%51%50%51%51%
EBITDA$24B$24B$22B$23B$24B
EBITDA Margin27%28%27%28%28%
EBIT Margin24%24%23%24%24%
Net Profit$17B$17B$15B$15B$16B
Net Margin19%20%18%18%19%
Net Debt-$25B---

Financial data powered by Morningstar, Inc.

Procter & Gamble Stock Performance

Procter & Gamble has current market cap of $328B, and enterprise value of $353B.

Market Cap Evolution


Procter & Gamble's stock price is $141.57.

Procter & Gamble share price decreased by 11.1% in the last year.

Procter & Gamble has an EPS (earnings per share) of $7.20.

See more trading valuation data for Procter & Gamble
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$353B$328B0.0%--2.0%-11.1%$7.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Procter & Gamble Valuation Multiples

Procter & Gamble trades at 4.1x EV/Revenue multiple, and 14.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Procter & Gamble

EV / Revenue (LTM)


Procter & Gamble Financial Valuation Multiples

As of June 5, 2026, Procter & Gamble has market cap of $328B and EV of $353B.

Procter & Gamble has a P/E ratio of 19.7x.

LTMLast FY202320242025202620272028
EV/Revenue4.1x4.2x4.3x4.2x4.1x
EV/EBITDA14.9x14.8x15.9x15.2x14.8x
EV/EBIT17.2x17.3x18.6x17.5x17.2x
EV/Gross Profit8.1x8.2x8.6x8.2x8.1x
P/E19.7x19.5x22.2x21.3x20.1x
EV/FCF23.2x24.6x23.3x23.1x24.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Procter & Gamble Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Procter & Gamble Margins & Growth Rates

Procter & Gamble grew revenue by 3% but EBITDA decreased by 1% in the last fiscal year.

In the most recent fiscal year, Procter & Gamble reported gross margin of 51%, EBITDA margin of 28%, and net margin of 20%.

See estimated margins and future growth rates for Procter & Gamble

Procter & Gamble Margins

Last FY202420252026202720282029
Gross Margin51%51%51%50%
EBITDA Margin28%28%28%27%
EBIT Margin24%24%24%24%
Net Margin20%18%19%19%
FCF Margin17%18%17%18%

Procter & Gamble Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%1%2%3%
Gross Profit Growth2%5%1%2%
EBITDA Growth(1%)5%2%1%
EBIT Growth0%6%2%2%
Net Profit Growth(1%)4%6%3%
FCF Growth6%1%(4%)6%

Data powered by FactSet, Inc. and Morningstar, Inc.

Procter & Gamble Operational KPIs

Procter & Gamble's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.2M for the same period.

Procter & Gamble's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Procter & Gamble's Rule of X is 35% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Procter & Gamble
LTMLast FY202320242025202620272028
Rule of 4030%30%---
Bessemer Rule of X35%35%---
Revenue per Employee-$0.8M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue12%11%-11%11%
R&D Expenses to Revenue3%2%-2%3%
Opex to Revenue-27%27%27%26%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Procter & Gamble Competitors

Procter & Gamble competitors include AbbVie, L'Oreal, Novo Nordisk, Unilever, EssilorLuxottica, Colgate-Palmolive, Hindustan Unilever, Galderma and Bayer.

Most Procter & Gamble public comparables operate across Health & Beauty and Home Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
AbbVie7.5x7.2x19.0x16.6x
L'Oreal4.4x4.4x18.7x18.3x
Novo Nordisk4.4x4.5x8.8x9.4x
Unilever2.4x2.4x10.7x10.7x
EssilorLuxottica3.0x3.0x12.6x12.3x
Colgate-Palmolive3.7x3.6x15.0x14.9x
Hindustan Unilever7.5x7.4x30.7x31.5x

This data is available for Pro users. Sign up to see all Procter & Gamble competitors and their valuation data.

Start Free Trial

Acquisitions by Procter & Gamble

Procter & Gamble has acquired 12 companies to date.

Last acquisition by Procter & Gamble was on January 22nd 2026. Procter & Gamble acquired Wonderbelly for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Procter & Gamble

Wonderbelly
Mielle Organics
TULA
OUAI
Description
Wonderbelly is a Denver-headquartered brand offering digestive health supplements like FODY Foods low-FODMAP products. Founded in 2019, it ships to 20 countries via Amazon, with clinical trials showing 70 percent symptom relief for IBS sufferers. Ingredients include digestive enzymes and prebiotics sourced from U.S. farms.
Mielle Organics is a hair care brand specializing in textured hair products with certified organic ingredients. Founded in Phoenix, Arizona, the company offers shampoos, conditioners, oils, and styling creams formulated with biotin, rosemary, and mongongo oil for curl patterns from wavy to coily. Distributed through Ulta Beauty and Target, Mielle expanded into retail partnerships with Sally Beauty in 2022.
TULA is a skincare brand that develops products featuring probiotic extracts and prebiotics in cleansers, moisturizers, masks, and serums to balance the skin microbiome. The lineup addresses concerns like dryness, breakouts, and dullness through formulations with lactobacillus ferment and hibiscus. Sold nationwide at Sephora, Ulta Beauty, and Target since its 2013 launch, TULA ships directly from its New York headquarters via tula.com to customers in the United States and Canada.
OUAI is a Los Angeles-headquartered haircare brand founded by celebrity stylist Jen Atkin. It sells shampoos, conditioners, styling products, and perfumes through its website and retailers like Sephora. OUAI's formulations include Detox Shampoo with apple cider vinegar and Wave Spray for beachy texture. The brand expanded to Asia and Europe in 2022.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Austin, TX
Crown Point, IN
New York City, NY
Los Angeles, CA
Deal Date22 Jan 202611 Jan 20234 Jan 20227 Dec 2021
Valuationundisclosed$640Mundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Procter & Gamble acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Procter & Gamble

Procter & Gamble has invested in 3 companies to date.

Latest investment by Procter & Gamble was on January 20th 2025. Procter & Gamble invested in Detergenti in their $19M Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Procter & Gamble

Detergenti
Moodify
Grin
Description
Detergenti is a manufacturer of detergents, soaps, disinfectants, and industrial cleaning agents for household and commercial use. Its product line includes laundry powders, floor cleaners, and hand sanitizers distributed in Italy and Europe.
Moodify is a Tel Aviv-based biotechnology firm developing AI-driven fragrance creation platforms. Leveraging neuroscience data from the Weizmann Institute and machine learning algorithms, it optimizes scent formulations for perfumes, detergents, and personal care products. The platform accelerates design cycles from months to days, ensures regulatory compliance with IFRA standards, and reduces material waste through predictive modeling. Clients in the global flavor and fragrance industry use its cloud-based tools for virtual screening of thousands of molecular combinations.
Grin is a New York and Austin-headquartered digital orthodontics platform connecting patients to local orthodontists via app-based remote monitoring. Featuring the Grin Scope for intraoral scans and aligners for mild to complex cases, it supports over 500 practitioners across the U.S. Founded in 2019, Grin facilitates treatments compliant with AAO standards through telemedicine.
HQ CountryRomaniaIsraelUnited States
HQ City
Ploiesti
Kfar Saba
New York City, NY
Deal Date20 Jan 202519 Aug 202129 Apr 2021
RoundStrategic investmentSeries ASeed
Raised$19M$8M$10M
InvestorsProcter & GambleNext Gear Ventures; non sibi ventures; OurCrowd; Procter & Gamble; Taisho Pharmaceutical Holdings; Toyota VenturesProcter & Gamble; SpringRock Ventures; Triventures
Valuationundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Procter & Gamble investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Procter & Gamble

When was Procter & Gamble founded?Procter & Gamble was founded in 1905.
Where is Procter & Gamble headquartered?Procter & Gamble is headquartered in United States.
How many employees does Procter & Gamble have?As of today, Procter & Gamble has over 109K employees.
Who is the CEO of Procter & Gamble?Procter & Gamble's CEO is Jon R. Moeller.
Is Procter & Gamble publicly listed?Yes, Procter & Gamble is a public company listed on NYSE.
What is the stock symbol of Procter & Gamble?Procter & Gamble trades under PG ticker.
When did Procter & Gamble go public?Procter & Gamble went public in 1950.
Who are competitors of Procter & Gamble?Procter & Gamble main competitors include AbbVie, L'Oreal, Novo Nordisk, Unilever, EssilorLuxottica, Colgate-Palmolive, Hindustan Unilever, Galderma, Bayer.
What is the current market cap of Procter & Gamble?Procter & Gamble's current market cap is $328B.
What is the current revenue of Procter & Gamble?Procter & Gamble's last 12 months revenue is $87B.
What is the current revenue growth of Procter & Gamble?Procter & Gamble revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Procter & Gamble?Current revenue multiple of Procter & Gamble is 4.1x.
What is the current EBITDA of Procter & Gamble?Procter & Gamble's last 12 months EBITDA is $24B.
What is Procter & Gamble's EBITDA margin?Procter & Gamble's last 12 months EBITDA margin is 27%.
What is the current EV/EBITDA multiple of Procter & Gamble?Current EBITDA multiple of Procter & Gamble is 14.9x.
What is the current FCF of Procter & Gamble?Procter & Gamble's last 12 months FCF is $15B.
What is Procter & Gamble's FCF margin?Procter & Gamble's last 12 months FCF margin is 18%.
What is the current EV/FCF multiple of Procter & Gamble?Current FCF multiple of Procter & Gamble is 23.2x.
How many companies Procter & Gamble has acquired to date?As of June 2026, Procter & Gamble has acquired 12 companies.
What was the largest acquisition by Procter & Gamble?$4B acquisition of Merck Consumer Healthcare on 19th April 2018 was the largest M&A Procter & Gamble has done to date.
What companies Procter & Gamble acquired?Procter & Gamble acquired Merck Consumer Healthcare, Mielle Organics, Farmacy Beauty, First Aid Beauty, THIS IS L, Native, Walker & Company Brands, Wonderbelly, Pressbox, TULA, and 2 other companies.
In how many companies Procter & Gamble has invested to date?As of June 2026, Procter & Gamble has invested in 3 companies.
What was the last Procter & Gamble investment?On 20th January 2025 Procter & Gamble invested in Detergenti, participating in a $19M Strategic investment round.
In what companies Procter & Gamble invested in?Procter & Gamble invested in Detergenti, Grin, and Moodify.

See public comps similar to Procter & Gamble

Lists including Procter & Gamble

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial